23975-23-7 Usage
Purpose
Treatment for narcolepsy, shift work sleep disorder, and obstructive sleep apnea
Function
Increases alertness and reduces the tendency to fall asleep during the day
Classification
Central nervous system stimulant
Mechanism of action
Influences certain neurotransmitters in the brain involved in regulating wakefulness and sleep (not completely understood)
Form
Tablet
Dosage
Typically taken once daily in the morning (follow healthcare professional's instructions)
Side effects
Headache, nausea, nervousness, and difficulty sleeping
Interactions
May interact with certain other medications
Precaution
Discuss use with a doctor before starting treatment to minimize risk of side effects and potential for dependence
Check Digit Verification of cas no
The CAS Registry Mumber 23975-23-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,9,7 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 23975-23:
(7*2)+(6*3)+(5*9)+(4*7)+(3*5)+(2*2)+(1*3)=127
127 % 10 = 7
So 23975-23-7 is a valid CAS Registry Number.
23975-23-7Relevant articles and documents
Lithiated sulfoxides: α-Sulfinyl functionalized carbanions
Ludwig, Gerd,Rüffer, Tobias,Hoppe, André,Walther, Till,Lang, Heinrich,Ebbinghaus, Stefan G.,Steinborn, Dirk
, p. 5323 - 5330 (2015)
Reactions of alkyl aryl sulfoxides H-CRR′S(O)Ar with n-BuLi-TMEDA (TMEDA = N,N,N′,N′-tetramethylethylenediamine) afforded α-sulfinyl functionalized alkyl aryl lithium compounds of the type [Li2{CRR′S(O)Ar}2(TMEDA)2] (1, R/
